English EN Spanish ES French FR Chinese (Simplified) ZH-CN
Print Friendly, PDF & Email

NCT/Study#

NCT03584516 /

INCB-39110-309

GRAVITAS-309: A Phase 2/3 Study of Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

DISEASE GROUP:
Transplant
current phase:
Phase II/III
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: